Approval · Notice of Compliance 24294 · 2020
MINT-CIPROFLOX: Notice of Compliance 24294
Issued September 24, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24294
- Date
- September 24, 2020
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to product monograph and labelling update to match licensor
- Canadian reference product
- IPG-CIPROFLOXACIN (Marcan Pharmaceuticals Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-CIPROFLOX | Not yet assigned | — |
Medicinal ingredients
- CIPROFLOXACIN HYDROCHLORIDE 250 MG per TAB
- CIPROFLOXACIN HYDROCHLORIDE 500 MG per TAB
- CIPROFLOXACIN HYDROCHLORIDE 750 MG per TAB